SEC Form 5 · accession 0001144204-16-081613
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ambra Thomas E D
Director · Other
Period of report
Dec 31, 2015
Accepted (ET)
Feb 12, 2016 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 10, 2015 | G | 2,500 | $0.00 | D | 2,511,373 | D | |
| Common StockF1 | Aug 19, 2015 | G | 10,000 | $0.00 | D | 2,501,373 | D | |
| Common StockF1 | Dec 1, 2015 | G | 3,000 | $0.00 | D | 2,498,373 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction is a bona fide gift from Dr. Thomas E. D Ambra and his spouse, Constance D Ambra.